ZURICH, July 23 (Reuters) - Roche Holding AG’s (ROG.VX: Quote, Profile, Research) decision to split the roles of chief executive and chairman, even as it unveiled set of stellar results, may up the pressure on cross-town rival Novartis AG’s (NOVN.VX: Quote, Profile, Research) Daniel Vasella.
